Merger and acquisition trends in the United States healthcare industry are fundamentally driven by the continuously changing models to pay for and assume the costs and risks of providing healthcare services. More recently, the industry has undertaken a grassroots transition in the basic business relationships throughout the system as participants reorganize to accommodate a shift from activity-based to value/risk-based reimbursement.
This white paper examines the trends in healthcare merger and acquisition activity overall, and by sector in 2012 and for the first half of 2013. Given our focus on healthcare services, we have intentionally limited the overview of certain sectors in our report, such as biotech, pharmaceuticals, and medical devices. Going forward, H2C intends to publish in-depth reports analyzing the activity within each healthcare service sector to highlight key observations, trends and notable M&A transactions and issues to help keep our clients and friends of the firm informed.